Ventures
Sean Cheng

Sean Cheng

Principal,
Venture Investments

Current role

Sean is a principal on the investment side of Philips Ventures in Boston and also serves as Venture Investment Lead for Image-Guide Therapy businesses. He’s worked in healthcare policy and strategy for 15 years. He also helped found two start-ups focused on wellness robotics and left ventricular device (LVAD) technology for people with heart failure. 

 

Sean is passionate about the potential of remote patient care, digital front door, digital diagnostics and therapeutics, cybersecurity and disruptive technologies like artificial intelligence and natural language processing.

Experience

Before joining Philips Ventures, Sean led Philips Group Strategy initiatives, which helped drive innovations in the company’s health cloud commercialization and wearables market. He’s also worked in policy at the FDA Center for Devices and Radiological Health and the Boston Consulting Group and medical device research at Johns Hopkins and Cambridge University. Sean is on the board of Orbita and is an observer at Babyscripts and other Philips Ventures investments. He holds a PhD in Engineering from Cambridge University and BSci Biomedical Engineering from Johns Hopkins.

Areas of focus

 

  • Digital therapeutics
  • Cybersecurity
  • D2C health
  • Remote patient monitoring (software & wearables)

Want to become a start-up partner with Philips Ventures?

Contact information

* This field is mandatory

*
*
*
*
*

*
*
*
 
Changing healthcare

Together, we’re changing healthcare

Together, we’re changing healthcare

Philips Ventures champions innovative start-ups with breakthrough solutions.

You are about to visit a Philips global content page

Continue

You are about to visit a Philips global content page

Continue

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.

You are entering a Philips Healthcare Australia website
Please select the checkbox

The information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).

By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.